GSE189859 GSE189861 IDH1 knockout 3 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE189859_GSE189861_IDH1 knockout_3_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE189859_GSE189861_IDH1 knockout_3_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE189859_GSE189861_IDH1 knockout_3_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE189859_GSE189861_IDH1 knockout_3_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 5

Gene

MIR1915 host gene

Gene

MAGI2 antisense RNA 3

Gene

uncharacterized LOC645485

Gene

contactin associated protein family member 3C

Gene

long intergenic non-protein coding RNA 842

Gene

SMIM29 antisense RNA 1

Gene

LYPLAL1 divergent transcript

Gene

ITGB1 divergent transcript

Gene

solute carrier family 22 member 20, pseudogene

  • Gene

    small nucleolar RNA host gene 5



  • Gene

    MAGI2 antisense RNA 3


  • Gene

    uncharacterized LOC645485


  • Gene

    contactin associated protein family member 3C


  • Gene

    long intergenic non-protein coding RNA 842


  • Gene

    SMIM29 antisense RNA 1


  • Gene

    LYPLAL1 divergent transcript


  • Gene

    ITGB1 divergent transcript


  • Gene

    solute carrier family 22 member 20, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.